Cancer Research CR  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 20, 1154-, September 1, 1960]
© 1960 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okada, T. A.
Right arrow Articles by Roberts, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okada, T. A.
Right arrow Articles by Roberts, E.

Cytological Analysis of Effects of Maleuric Acid on Ehrlich Ascites Tumor Cells*

Tadashi A. Okada and Eugene Roberts

( Department of Biochemistry, Medical Research Institute, City of Hope Medical Center, Duarte, Calif.)

The injection of MA (N-carbamylmaleamic acid) into mice bearing the Ehrlich ascites tumor produced cytoplasmic blebbing and mitotic abnormalities in all phases of mitosis, inhibited the incorporation of tritiated thymidine into DNA, and prevented the progression of premitotic cells into mitosis, lesser effects being observed with smaller doses of MA. Analyses of sequential changes showed MA to be more effective intraperitoneally than subcutaneously. Cumulative effects of multiple subcutaneous doses could be demonstrated. Of a variety of substances tested, only glutathione (GSH) prevented the effects of MA. Observable effects of intraperitoneally injected MA were abolished when MA was premixed with an isomolar amount of GSH or when excess GSH was injected simultaneously or 5 minutes after MA. Fewer abnormalities were observed in the tumor cells even when GSH was given 60 minutes after MA.

* This work was supported in part by research grant C-2568 from the National Cancer Institute, National Institutes of Health, Public Health Service.

Received 1/21/60.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1960 by the American Association for Cancer Research.